Tested Applications
| Positive IHC detected in | human malignant melanoma tissue, human lung tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:2000-1:8000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
60348-1-Ig targets Melan-A in IHC, IF, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse, monkey |
| Host / Isotype | Mouse / IgG2a |
| Class | Monoclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag13387 Product name: Recombinant human MLANA protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 1-118 aa of BC014423 Sequence: MPREDAHFIYGYPKKGHGHSYTTAEEAAGIGILTVILGVLLLIGCWYCRRRNGYRALMDKSLHVGTQCALTRRCPQEGFDHRDSKVSLQEKNCEPVVPNAPPAYEKLSAEQSPPPYSP Predict reactive species |
| Full Name | melan-A |
| Calculated Molecular Weight | 13 kDa |
| GenBank Accession Number | BC014423 |
| Gene Symbol | MelanA |
| Gene ID (NCBI) | 2315 |
| RRID | AB_2881457 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Protein A purification |
| UNIPROT ID | Q16655 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Melan-A is a melanocyte differentiation antigen, recognized by autologous cytotoxic T lymphocytes. Melan-A is also called MART-1 (melanoma antigen recognized by T cells). The Melan-A/MART-1 gene encodes this protein, 20-22 kDa, associated with endoplasmic reticulum and melanosomes. The function of the protein is unknown. Melan-A, isolated as a melanoma-specific antigen, is a transmembrane protein, which is expressed in skin, retina and the majority of cultured melanocytes as well as in melanomas. Melan A is expressed in more than 85% of melanomas.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for Melan-A antibody 60348-1-Ig | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The Melan-A (MART-1) Monoclonal antibody (60348-1-Ig) has 7 citations total. Publications appear in Cancer Communications, Investigative Ophthalmology & Visual Science, Inflammation, Scientific Reports (2 papers), Biochimica et Biophysica Acta – Molecular Cell Research, and Cell Reports Medicine. The cited research spans oncology (mucosal melanoma, multidrug resistance), ophthalmology (limbal stem cell niche, marmoset cochlea), dermatology (vitiligo, melanocyte apoptosis under ER stress), and cell/molecular biology, with applications including IF and IHC across human, mouse, and monkey samples.
| Species | Application | Title |
|---|---|---|
Cancer Commun (Lond) Candidate therapeutic agents in a newly established triple wild-type mucosal melanoma cell line. | ||
Invest Ophthalmol Vis Sci The Spatial Transcriptomic Atlas of Human Limbus and Vital Niche Microenvironment Regulating the Fate of Limbal Epithelial Stem Cells | ||
Inflammation Sirtuin1 Deficiency Could Exacerbate Melanocyte Apoptosis Under Endoplasmic Reticulum Stress | ||
Sci Rep Distinct Connexin43, Connexin31, and Pannexin1 expression patterns in the cochlea of a non-human primate. | ||
Sci Rep Cell-specific α and β subunit expression patterns of Na+/K+-ATPases in the common marmoset cochlea | ||
Biochim Biophys Acta Mol Cell Res MitoQ for vitiligo by mitigating PARP1 translocation aberrations: Network pharmacology and experimental validation |











